Maravai LifeSciences Holdings Inc - Class A (MRVI) Company Profile & Statistics

Maravai LifeSciences Holdings Inc - Class A
MRVI
(Nasdaq - US)
Closed
7.36
+0.06 (+0.75%)
in:usd•As of: Apr 22, 2024 15:59 UTC -4
Open
7.32
High
7.50
Low
7.26

About Maravai LifeSciences Holdings Inc - Class A

CEO

William E. Martin, III

Headquarters

10770 wateridge circle suite 200

san diego, ca 92121, united states

Auditor

Ernst & Young LLP

Employees

650

Share Holders

Website

www.maravai.com

Industry

biotechnology

Sector

health technology

Company Overview

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

Maravai LifeSciences Holdings Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	1.84B
Enterprise Value	1.82B
Enterprise Value/EBITDA (ttm)	90.57
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.32
Price to Sales (ttm)	6.35
Price to Cash (ytd)	77.08

Profitability

Gross Margin (ttm)	48.09%
Operating Margin (ttm)	-3.94%
Profit Margin (ttm)	-40.54%
Return on Equity (ttm)	-1.31%
Return on Invested Capital (ttm)	-10.17%
Return on Assets (ttm)	-0.55%

Income Statement

Revenue (ttm)	288.95M
Revenue Per Share (ttm)	1.15
Gross Profit (ttm)	140.20M
EBITDA (ttm)³	20.06M
Net Income Avi to Common (ttm)	-119.03M
Diluted EPS (ttm)	-0.90

Share Statistics

Beta (5Y Monthly)	0.01
52-Week Change	-48.82%
S&P500 52-Week Change	21.12%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	251.40M
Dividend Yield	0.00%
Float ⁴	250.85M
% Held by Insiders	0.22%
% Held by Institutions	50.25%

Balance Sheet

Total Cash (mrq)	574.96M
Total Cash Per Share (mrq)	2.29
Total Debt (mrq)	556.68M
Total Debt/Equity (mrq)	70.48%
Current Ratio (mrq)	8.00%
Quick Ratio (mrq)	7.41%
Book Value Per Share (mrq)	3.14

Cash Flow

Operating Cash Flow Per Share (ytd)	0.96
Free Cash Flow (ytd)	60.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Maravai LifeSciences Holdings Inc - Class A

Trade With A Regulated Broker